- Patent Title: Methods of using C1 esterase inhibitor for improving early onset and long-term function of kidney transplants from grafts associated with delayed graft function
-
Application No.: US16646539Application Date: 2018-09-14
-
Publication No.: US12059456B2Publication Date: 2024-08-13
- Inventor: Stanley Jordan , Jua Choi , Ashley Vo
- Applicant: Cedars-Sinai Medical Center
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinai Medical Center
- Current Assignee: Cedars-Sinai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: Nixon Peabody LLP
- International Application: PCT/US2018/051045 2018.09.14
- International Announcement: WO2019/055763A 2019.03.21
- Date entered country: 2020-03-11
- Main IPC: A61K38/57
- IPC: A61K38/57 ; A61K9/00
Abstract:
Described herein are methods for improving kidney function in subjects that have undergone kidney transplant. An effective amount of one or more complement component 1 esterase inhibitors is administered to the subject, resulting in long-term improvement on kidney allograft function.
Public/Granted literature
- US20200276283A1 METHODS FOR IMPROVING ORGAN FUNCTION IN ORGAN TRANSPLANT PATIENTS Public/Granted day:2020-09-03
Information query
IPC分类:
